A Multicenter, Open-Label, Randomized, Two-Arm Study of Irinotecan Versus the Combination of Oxaliplatin Plus Irinotecan as Second-Line Treatment of Metatastatic Colorectal Cancer

  • DeSimone, Philip (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/01 → 12/31/01